stockrow
Friday 6 November 2026
Export LMNR’s income statement to Excel — free account
Limoneira Co
LMNR Consumer Defensive Farm Products
Limoneira Co’s revenue for fiscal 2025 (year ended October 2025) was $159.7 million, down 16.6% from fiscal 2024.
- Revenue
- −7.73%
- EPS
- −183.3%
- Free cash flow
- +34.6%
- Total debt
- +60.2%
Quarter to July 2026, against a year earlier
10.64
0.23
+2.21%
Follow LMNR
Alert me
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.58 | 1.81 | 1.72 | 1.81 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
267.51 | (22.11) | (51.08) | 737.24 | |
P/B ratio |
1.40 | 1.53 | 1.49 | 1.55 | |
Price to Tangible BV |
1.43 | 1.56 | 1.53 | 1.59 | |
EV/Sales |
2.02 | 2.42 | 2.43 | 2.58 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(53.75) | (72.00) | (17.63) | (22.23) | |
EV/FCF |
(16.88) | (20.42) | (12.01) | (13.44) | |
Quick Ratio |
0.56 | 0.52 | 0.53 | 0.67 | |
Current Ratio |
1.35 | 1.16 | 1.68 | 1.51 | |
Net Debt/EBITDA |
(8.37) | (10.57) | (9.00) | 31.86 | |
Debt/Assets |
23.30% | 29.25% | 32.03% | 33.91% | |
Debt/Equity |
0.38 | 0.50 | 0.57 | 0.63 | |
Asset Turnover |
0.52 | 0.47 | 0.45 | 0.43 | |
Operating CF/Net income |
(0.11) | 1.23 | 0.21 | (0.11) | |
Capex/Depreciation |
(1.50) | (1.40) | 0.11 | (0.68) | |
Interest Coverage |
(12.57) | (13.54) | (38.74) | (2.66) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
17.07% | 25.23% | 22.65% | 9.16% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
1.94% | 1.89% | 1.26% | 0.89% | |
Graham Net Nets |
(0.32) | (0.39) | (0.39) | (0.42) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(6.58%) | (8.83%) | (17.91%) | (18.43%) | |
Free Cash Flow Yield |
(7.59%) | (6.57%) | (11.73%) | (10.62%) | |
Revenue per Share |
2.40 | 1.02 | 1.33 | 2.44 | |
Operating CF per Share |
0.05 | (0.66) | (0.25) | 0.02 | |
Capex per Share |
(0.22) | (0.17) | 0.07 | (0.23) | |
Free Cash Flow per Share |
(0.17) | (0.82) | (0.18) | (0.21) | |
Cash per Share |
0.08 | 0.07 | 0.05 | 0.12 | |
Shareholders Equity per Share |
10.70 | 10.09 | 9.13 | 8.97 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
10.70 | 10.09 | 9.13 | 8.97 | |
Free Cash Flow |
(2.97) | (14.75) | (3.16) | (3.84) | |
Working Capital |
10.39 | 3.61 | 16.71 | 13.19 | |
Capital Expenditures |
(3.91) | (3.01) | 1.30 | (4.16) | |
Net Current Asset Value |
(79.82) | (100.89) | (88.73) | (98.91) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.09 | 0.17 | (0.05) | 0.10 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
15.08 | 13.10 | 14.03 | 17.43 | |
Average Payables |
7.58 | 8.32 | 8.09 | 6.75 | |
Average Inventory |
2.14 | 1.95 | 3.28 | 2.49 | |
Average Assets |
304.98 | 304.45 | 295.24 | 299.63 | |
Average Common Equity |
185.86 | 178.19 | 167.79 | 165.40 |
Columns are period end dates